Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
Clinical trial NCT06453213 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06453213
- Sponsor
- SK Life Science, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-14
- Primary completion
- 2027-05-26
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.